What is the most common complication of TIPS (Transjugular Intrahepatic Portosystemic Shunt) procedure?
Transjugular intrahepatic portosystemic shunt (TIPS) is contraindicated in which of the following conditions?
In cerebral angiography, through which artery is the dye typically injected?
TIPS involves percutaneous creation of a shunt between which of the following structures?
Uterine artery embolisation is done by using which of the following agents?
Judkins technique is used for which procedure?
Which of the following statements is FALSE regarding Transjugular Intrahepatic Portosystemic Shunts (TIPS)?
What is an early complication following TIPSS?
Percutaneous vertebroplasty is not performed for which of the following conditions?
Therapeutic embolisation is indicated in all except?
Explanation: **Explanation:** **TIPS (Transjugular Intrahepatic Portosystemic Shunt)** is an artificial channel created between the high-pressure portal vein and the low-pressure hepatic vein to treat complications of portal hypertension. **Why Hepatic Encephalopathy (HE) is the correct answer:** The primary mechanism of TIPS involves bypassing the liver’s filtration system. By creating a shunt, portal blood (rich in ammonia and other neurotoxins derived from the gut) enters the systemic circulation directly without being detoxified by hepatocytes. This leads to **Hepatic Encephalopathy in approximately 25–45% of patients**, making it the most frequent complication post-procedure. **Analysis of Incorrect Options:** * **A. Heart Failure:** While the sudden increase in venous return to the right atrium (preload) can precipitate acute heart failure in patients with underlying cardiac disease, it is far less common than HE. * **C. Thrombosis:** Shunt stenosis or thrombosis was common with bare-metal stents; however, with the modern use of **PTFE-covered stents**, the incidence of thrombosis has significantly decreased. * **D. Recurrent Variceal Bleed:** TIPS is highly effective at decompressing varices. Re-bleeding usually only occurs if the shunt becomes occluded or stenosed, which is a secondary event. **High-Yield Clinical Pearls for NEET-PG:** * **Indications:** Refractory variceal bleeding (most common indication) and refractory ascites. * **Absolute Contraindications:** Severe congestive heart failure (Right-sided), polycystic liver disease, and severe active systemic infection/sepsis. * **Technical Goal:** To reduce the **Portosystemic Pressure Gradient (PSG) to <12 mmHg** to prevent re-bleeding. * **Stent Type:** PTFE-covered stents (e.g., VIATORR) are the gold standard to maintain patency.
Explanation: **Explanation:** **Transjugular Intrahepatic Portosystemic Shunt (TIPS)** is an interventional procedure where a shunt is created between the hepatic vein and the portal vein to reduce portal hypertension. **Why Portal Vein Thrombosis (PVT) is the correct answer:** The success of a TIPS procedure depends on the ability to access and pass a wire through the portal vein to establish the shunt. In cases of **extensive or cavernous portal vein thrombosis**, the target vessel is either occluded or replaced by small collateral vessels, making the procedure technically impossible or highly hazardous. While partial PVT is sometimes managed by experienced interventionists, complete PVT remains a classic **absolute contraindication** in standard practice. **Analysis of Incorrect Options:** * **Post-shunt encephalopathy (A):** This is a common **complication** of TIPS, not a contraindication for the initial procedure. However, pre-existing severe hepatic encephalopathy is a relative contraindication. * **Cirrhosis (B):** Cirrhosis with portal hypertension is the **primary indication** for TIPS (specifically for refractory ascites or variceal bleeding). * **Variceal bleeding (D):** This is a **major indication** for TIPS, especially when bleeding is refractory to endoscopic management (Rescue TIPS). **High-Yield Clinical Pearls for NEET-PG:** * **Absolute Contraindications:** Severe congestive heart failure (R-sided), severe pulmonary hypertension, and multiple hepatic cysts/polycystic liver disease. * **Relative Contraindications:** Active systemic infection, severe coagulopathy, and rapidly progressing hepatoma. * **MELD Score:** A MELD score >18 is associated with higher mortality post-TIPS. * **Mechanism:** TIPS bypasses the liver parenchyma, effectively converting sinusoidal portal hypertension into a side-to-side portocaval shunt.
Explanation: **Explanation:** The standard technique for cerebral angiography is the **Seldinger technique**, and the **Femoral artery** (specifically the common femoral artery) is the most common site of access. **1. Why the Femoral Artery is Correct:** The common femoral artery is the preferred choice because of its **large caliber**, superficial location against the femoral head (which allows for easy compression to achieve hemostasis), and its relatively straight anatomical course to the aorta. This provides the most direct and stable route for navigating large catheters into the carotid and vertebral arteries. **2. Analysis of Incorrect Options:** * **Brachial/Axillary Arteries:** These were used historically but are now rarely preferred due to a higher risk of neurovascular complications (e.g., brachial plexus injury) and a higher incidence of arterial spasm and thrombosis compared to the femoral route. * **Radial Artery:** While the **Transradial Approach (TRA)** is rapidly gaining popularity for both cardiac and cerebral interventions (due to lower bleeding risk and immediate ambulation), it is not yet the "typical" or traditional gold standard described in standard textbooks for NEET-PG purposes. **3. High-Yield Clinical Pearls for NEET-PG:** * **Seldinger Technique Steps:** Skin incision → Needle puncture of the artery → Guidewire insertion → Needle removal → Dilator/Sheath insertion over the wire. * **Gold Standard:** Digital Subtraction Angiography (DSA) remains the gold standard for diagnosing cerebral aneurysms and Arteriovenous Malformations (AVMs). * **Contrast Media:** Non-ionic, low-osmolar contrast agents (LOCM) are used to minimize neurotoxicity and allergic reactions. * **Post-Procedure:** After femoral access, the patient must remain supine with the leg extended for 4–6 hours to prevent hematoma formation.
Explanation: **Explanation:** **Transjugular Intrahepatic Portosystemic Shunt (TIPS)** is a life-saving interventional radiology procedure used primarily to manage complications of portal hypertension, such as refractory ascites and variceal bleeding. **Why the Correct Answer is Right:** The procedure involves accessing the **Internal Jugular Vein**, passing a catheter through the Right Atrium into the **Hepatic Vein** (usually the Right Hepatic Vein). From there, a needle is used to puncture through the liver parenchyma to reach a branch of the **Portal Vein**. A metallic stent is then deployed to create a low-resistance channel between these two systems, effectively bypassing the congested liver and decompressing the portal venous system. **Analysis of Incorrect Options:** * **Option A & C:** While the hepatic vein eventually drains into the **Vena Cava**, the shunt is anatomically placed directly between the portal and hepatic venous branches within the liver. A direct portal-to-vena cava shunt is a surgical procedure (Portacaval shunt), not TIPS. * **Option D:** The **Hepatic Artery** carries oxygenated blood *to* the liver. Shunting the portal vein into an artery would worsen portal hypertension and is physiologically incorrect. **High-Yield Clinical Pearls for NEET-PG:** * **Indications:** Refractory variceal bleeding (secondary prophylaxis) and refractory ascites. * **Absolute Contraindications:** Severe congestive heart failure (due to sudden increase in venous return), polycystic liver disease, and severe active systemic infection. * **Major Complication:** **Hepatic Encephalopathy** (due to bypass of nitrogenous waste detoxification) and stent stenosis. * **Goal:** To reduce the **Portosystemic Pressure Gradient (PSPG)** to <12 mmHg.
Explanation: **Explanation:** **Uterine Artery Embolization (UAE)** is a minimally invasive interventional radiology procedure primarily used for the treatment of symptomatic uterine fibroids and adenomyosis, as well as for controlling life-threatening postpartum hemorrhage. **Why Polyvinyl Alcohol (PVA) is correct:** The goal of UAE is to achieve permanent or semi-permanent occlusion of the small vessels supplying the fibroid, leading to ischemic necrosis while preserving the normal myometrium. **Polyvinyl Alcohol (PVA) particles** (typically 300–700 μm) are the gold standard embolic agents for this procedure. They are non-absorbable, biocompatible, and cause a mechanical block that triggers an inflammatory response and subsequent permanent vascular thrombosis. **Analysis of Incorrect Options:** * **Thrombin:** This is a potent procoagulant used primarily for the percutaneous treatment of **pseudoaneurysms** (e.g., femoral artery pseudoaneurysm) via direct injection. It is not used for distal embolization in UAE. * **Vitamin K:** This is a systemic medication used to reverse the effects of warfarin or treat Vitamin K deficiency. It has no role as a physical embolic agent in interventional radiology. * **Iodine:** Iodine is a component of **contrast media** used to visualize vessels during fluoroscopy. While essential for the procedure to guide the catheter, it does not possess embolic properties. **High-Yield Clinical Pearls for NEET-PG:** * **Access Site:** Usually the common femoral artery (trans-radial access is an emerging alternative). * **Other Embolic Agents:** Besides PVA, **Tris-acryl gelatin microspheres** are also commonly used. * **Temporary Embolization:** **Gelfoam** (absorbable gelatin sponge) is used when only temporary occlusion is needed, such as in acute trauma or certain cases of postpartum hemorrhage. * **Absolute Contraindications:** Pregnancy, active pelvic infection, and suspected uterine malignancy.
Explanation: **Explanation:** The **Judkins technique** is the most widely used method for **coronary arteriography** (Option B). Developed by Melvin Judkins in the late 1960s, it involves a percutaneous femoral artery approach (Seldinger technique) using pre-shaped, specialized catheters. * **Why it is correct:** The technique utilizes specific **Judkins Left (JL)** and **Judkins Right (JR)** catheters. These catheters have unique secondary curves designed to naturally seek and engage the orifices of the left and right coronary arteries, respectively, with minimal manipulation. This makes the procedure highly reproducible and efficient for visualizing coronary anatomy. **Analysis of Incorrect Options:** * **Option A (Central venous line):** Usually performed via the internal jugular or subclavian vein using the Seldinger technique, but does not involve Judkins-specific catheters. * **Option C (Renal angiography):** While also an arterial procedure, it typically uses different catheter shapes, such as the **Cobra** or **RDC (Renal Double Curve)** catheters. * **Option D (Chest tube insertion):** This is a bedside surgical procedure (tube thoracostomy) for draining the pleural space and does not involve specialized angiographic catheters. **High-Yield Clinical Pearls for NEET-PG:** * **Sones Technique:** An older alternative to Judkins that uses a brachial artery cut-down approach and a single universal catheter. * **Amplatz Catheters:** Often used as a second-line choice if the Judkins catheters fail to engage the coronary ostia (especially in dilated aortas). * **Seldinger Technique:** The fundamental "needle-wire-sheath" method used to gain vascular access before any Judkins procedure begins.
Explanation: **Explanation:** **1. Why Option A is False (The Correct Answer):** In the context of TIPS, **shunt stenosis** is significantly more common than acute shunt thrombosis. Stenosis typically occurs due to **pseudointimal hyperplasia** (accumulation of collagen and fibroblasts) within the stent or at the outflow hepatic vein. While the use of PTFE-covered stents (e.g., Viatorr) has drastically reduced these rates compared to bare-metal stents, stenosis remains the primary cause of long-term shunt dysfunction. **2. Analysis of Other Options:** * **Option B:** Hepatic encephalopathy (HE) occurs in approximately 20–30% of patients. By diverting portal blood directly into the systemic circulation, the liver’s "first-pass" detoxification of ammonia is bypassed, leading to neurotoxicity. * **Option C:** TIPS reduces portal pressure, which addresses the underlying pathophysiology of refractory ascites and hepatic hydrothorax, often leading to significant clinical improvement. * **Option D:** Clinical trials consistently show that TIPS is superior to endoscopic variceal ligation (EVL) and pharmacological therapy in preventing re-bleeding, although it carries a higher risk of HE. **3. High-Yield Clinical Pearls for NEET-PG:** * **Primary Indication:** Refractory variceal bleeding and refractory ascites. * **Anatomy:** The shunt is most commonly created between the **Right Hepatic Vein** and the **Right Portal Vein**. * **Absolute Contraindications:** Severe congestive heart failure (due to sudden increase in venous return), severe pulmonary hypertension, and polycystic liver disease. * **MELD Score:** A high MELD score (>18) is a predictor of poor prognosis post-TIPS.
Explanation: **Explanation:** **Transjugular Intrahepatic Portosystemic Portosystemic Shunt (TIPSS)** is a procedure used to manage complications of portal hypertension by creating a low-resistance channel between the portal vein and the hepatic vein. **Why Capsule Rupture and Bleeding is the correct answer:** During the procedure, a needle is passed from the hepatic vein through the liver parenchyma to puncture the portal vein. If the needle trajectory is too peripheral or if the puncture is misplaced, it can breach the **Glisson’s capsule**, leading to immediate intraperitoneal hemorrhage. This is considered an **early/procedural complication** occurring during or immediately after the intervention. **Analysis of Incorrect Options:** * **A. Encephalopathy:** While a common complication (occurring in ~25-35% of patients), hepatic encephalopathy typically develops in the **subacute phase** (weeks to months) as unfiltered portal blood reaches the systemic circulation. * **C. Shunt Stenosis:** This is a **late complication** (months to years) usually caused by pseudointimal hyperplasia within the stent. * **D. Shunt Thrombosis:** This can occur early or late, but it is less common than bleeding as an immediate procedural risk in the modern era of covered stents. **High-Yield Clinical Pearls for NEET-PG:** * **Indications:** Refractory ascites and variceal bleeding unresponsive to endoscopic therapy. * **Contraindications:** Severe congestive heart failure (absolute), polycystic liver disease, and severe hepatic encephalopathy. * **Preferred Stent:** PTFE-covered stents (e.g., Viatorr) are preferred over bare metal stents as they significantly reduce the rates of shunt stenosis and occlusion. * **Follow-up:** Doppler Ultrasound is the primary modality to monitor shunt patency.
Explanation: **Explanation:** Percutaneous Vertebroplasty (PVP) is a minimally invasive procedure where bone cement (Polymethylmethacrylate - PMMA) is injected into a vertebral body to provide mechanical stability and pain relief. **Why Tuberculosis is the Correct Answer:** Vertebroplasty is generally **contraindicated in active infections** like Tuberculosis (Pott’s spine) or pyogenic osteomyelitis. Injecting bone cement into an infected area can worsen the infection, act as a foreign body nidus for bacteria/mycobacteria, and interfere with the penetration of antitubercular drugs. Furthermore, TB often involves the posterior elements or causes significant epidural abscesses, where decompression surgery is preferred over stabilization via cement. **Analysis of Incorrect Options:** * **Osteoporosis:** This is the **most common indication** for vertebroplasty. It is used to treat painful osteoporotic vertebral compression fractures (VCFs) that do not respond to conservative management. * **Hemangioma:** Symptomatic or aggressive vertebral hemangiomas are a classic indication. The cement provides structural support and helps reduce the vascularity of the lesion. * **Metastasis:** Vertebroplasty is frequently used for palliative care in painful osteolytic metastatic lesions or Multiple Myeloma to prevent pathological fractures and reduce pain. **Clinical Pearls for NEET-PG:** * **Absolute Contraindications:** Active systemic or local infection, uncorrected coagulopathy, and asymptomatic fractures. * **Relative Contraindication:** Fracture fragment protruding into the spinal canal (risk of cord compression). * **Complication:** The most common complication is **cement leakage**. While usually asymptomatic, it can lead to pulmonary embolism or nerve root compression. * **Kyphoplasty vs. Vertebroplasty:** Kyphoplasty involves inflating a balloon first to restore vertebral height before injecting cement, whereas vertebroplasty is a direct high-pressure injection.
Explanation: **Explanation:** The core principle of **therapeutic embolization** is the intentional occlusion of a blood vessel to stop hemorrhage, devitalize a tumor, or eliminate an abnormal vascular communication. **Why Aneurysms is the correct answer (The "Except"):** While interventional radiology is used to treat aneurysms, the goal is **exclusion** or **filling** of the aneurysmal sac (e.g., via endovascular coiling or flow-diverter stents) rather than "embolization" of the parent artery itself. Embolizing (blocking) the main artery supplying an aneurysm would lead to distal ischemia and infarction of the organ or tissue it supplies. Therefore, while "coiling" is a form of endovascular treatment, traditional therapeutic embolization is generally contraindicated for the parent vessel of an aneurysm. **Analysis of Incorrect Options:** * **Hemangioma:** Embolization is used to reduce the size of symptomatic or giant hemangiomas and to minimize intraoperative blood loss before surgical excision. * **Renal Cell Carcinoma (RCC):** Pre-operative embolization is a standard practice for large, vascular RCCs. It reduces intraoperative blood loss and "devitalizes" the tumor by cutting off its primary blood supply (usually the renal artery). * **AV Fistula:** Embolization is the treatment of choice for abnormal communications between arteries and veins. Agents like coils, glues (cyanoacrylate), or plugs are used to close the fistula tract directly. **NEET-PG High-Yield Pearls:** * **Common Embolizing Agents:** Gelfoam (temporary), Coils/Plugs (permanent), Polyvinyl Alcohol (PVA) particles, and Absolute Alcohol (sclerosant). * **Absolute Alcohol** is the agent of choice for **Arteriovenous Malformations (AVMs)**. * **Post-embolization Syndrome:** A common triad of pain, fever, and leukocytosis occurring after the procedure due to tissue ischemia/necrosis.
Explanation: **Explanation:** Arterial embolization is a minimally invasive interventional radiology procedure used to occlude blood flow to a specific area, either to control active bleeding or to devascularize a lesion. **Why Option D is the Correct Answer:** **Endometriosis** is a chronic inflammatory condition characterized by the presence of endometrial-like tissue outside the uterus. The primary management is medical (hormonal therapy) or surgical (excision/ablation). Arterial embolization is **not** a standard or indicated treatment for the "prevention of bleeding" in endometriosis, as the bleeding is cyclical and diffuse rather than originating from a single targetable vessel. **Analysis of Incorrect Options:** * **A. Uterine Arteriovenous Malformation (AVM):** Embolization (usually with glue or coils) is the **gold standard** treatment for uterine AVMs, especially in patients wishing to preserve fertility. * **B. Postpartum Hemorrhage (PPH):** Uterine Artery Embolization (UAE) is a life-saving intervention for refractory PPH when conservative measures fail, serving as an alternative to emergency hysterectomy. * **C. Malignant Tumors:** Embolization is widely used in oncology to treat hypervascular tumors (e.g., Renal Cell Carcinoma) or as part of **Transarterial Chemoembolization (TACE)** for Hepatocellular Carcinoma to induce tumor necrosis. **NEET-PG High-Yield Pearls:** * **Uterine Artery Embolization (UAE):** Most commonly performed for symptomatic **Uterine Fibroids** (Leiomyomas). * **Embolic Agents:** Know the types—**Permanent** (Coils, PVA particles, Glue/NBCA) vs. **Temporary** (Gelfoam). * **Bronchial Artery Embolization (BAE):** The treatment of choice for **massive hemoptysis**. * **Contraindication:** Avoid embolization if there is an uncorrectable coagulopathy or severe renal failure (due to contrast use).
Explanation: **Explanation:** **Transjugular Intrahepatic Portosystemic Portosystemic Shunt (TIPSS)** is a procedure used to create a low-resistance channel between the portal vein and the hepatic vein to reduce portal hypertension. **Why Hepatic Porto-splenic (Hepatopulmonary) Syndrome (HPS) is a Contraindication:** HPS is characterized by intrapulmonary vascular dilatations leading to a right-to-left shunt and hypoxemia. TIPSS increases venous return to the right heart and subsequently increases pulmonary blood flow. In a patient with HPS, this exacerbates the intrapulmonary shunting, worsening hypoxemia and potentially leading to acute right heart failure. Therefore, severe HPS is considered a relative to absolute contraindication. **Analysis of Incorrect Options:** * **Hepatorenal Syndrome (HRS):** TIPSS is actually a **therapeutic indication** for Type 1 HRS. By reducing portal pressure, it improves systemic hemodynamics and renal perfusion. * **Veno-occlusive Disease (VOD):** Now often termed Sinusoidal Obstruction Syndrome (SOS), TIPSS can be used as a salvage therapy to decompress the liver in severe cases. * **Budd-Chiari Syndrome (BCS):** TIPSS is a **standard treatment** for BCS when medical management or angioplasty fails, as it bypasses the hepatic venous outflow obstruction. **High-Yield Clinical Pearls for NEET-PG:** * **Absolute Contraindications:** Congestive heart failure (Right-sided), severe pulmonary hypertension, polycystic liver disease, and uncontrolled systemic infection/sepsis. * **Relative Contraindications:** Hepatocellular carcinoma (HCC) obstructing the shunt path, severe coagulopathy, and HPS. * **MELD Score:** A MELD score >18-24 is associated with higher mortality post-TIPSS. * **Most Common Complication:** Hepatic encephalopathy (due to bypass of nitrogenous waste filtration).
Explanation: **Explanation:** **TIPS (Transjugular Intrahepatic Portosystemic Shunt)** is a percutaneous procedure used to manage complications of portal hypertension, such as refractory ascites and variceal bleeding. **Why Option D is Correct:** TIPS is considered the "bridge to transplantation." Unlike surgical shunts, TIPS is performed via a minimally invasive vascular approach and does not involve entering the peritoneal cavity. This preserves the anatomy of the hepatic hilum and avoids the formation of dense surgical adhesions, which significantly reduces the technical difficulty and morbidity of a future liver transplant surgery. **Analysis of Incorrect Options:** * **Option A:** TIPS is a **Side-to-Side Portosystemic Shunt**, specifically connecting a branch of the **Portal Vein** (usually the right branch) to a **Hepatic Vein** (usually the right hepatic vein), which then drains into the IVC. It is not a direct portocaval shunt. * **Option B:** While the shunt itself is located within the liver parenchyma (intrahepatic), the term "intrahepatic shunt" is often used broadly. However, in the context of NEET-PG, the most clinically significant "true" statement regarding its utility is its role in transplant candidates. * **Option C:** TIPS is an **Interventional Radiology** procedure performed under fluoroscopic (X-ray) guidance using a transjugular venous approach. It is **not** an endoscopic procedure. **High-Yield Clinical Pearls for NEET-PG:** * **Route:** Internal Jugular Vein → Superior Vena Cava → Right Atrium → Inferior Vena Cava → Hepatic Vein → Portal Vein. * **Absolute Contraindications:** Severe congestive heart failure (due to sudden increase in venous return), severe pulmonary hypertension, and polycystic liver disease. * **Major Complication:** **Hepatic Encephalopathy** (occurs in ~25-30% of patients) because blood bypasses the liver's detoxification process. * **Primary Indication:** Refractory variceal bleeding and refractory ascites.
Explanation: **Explanation:** **Glomus Jugulare** (Paraganglioma) is a highly vascular, slow-growing tumor arising from the jugular bulb. Because it originates in the skull base, it frequently involves the carotid canal and can encase or compress the internal carotid artery (ICA). **Why MR Angiography (MRA) is the correct answer:** MRA is the preferred non-invasive modality to assess the relationship between the tumor and the surrounding vasculature. It provides high-contrast resolution to differentiate the tumor mass from the vessel lumen. Specifically, it can demonstrate **arterial narrowing, displacement, or encasement** (the "Lyre sign" is more common in carotid body tumors, but vessel displacement is a hallmark here too). It helps in surgical planning by evaluating the patency of the ICA without the risks of ionizing radiation or iodinated contrast. **Analysis of Incorrect Options:** * **CECT:** While excellent for showing "moth-eaten" bone destruction of the jugular foramen, it lacks the precise flow-dynamics and vascular detail provided by MRA to specifically diagnose arterial compression. * **X-ray:** This is an obsolete modality for soft tissue or vascular assessment of the skull base. It cannot visualize the carotid artery or the tumor. * **Jugular Venography:** While historically used to show filling defects in the jugular vein, it does not provide information regarding the **carotid artery**, which is the focus of the question. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Sign:** On MRI, Glomus tumors show a **"Salt and Pepper" appearance** (Salt = subacute hemorrhage; Pepper = flow voids of high vascularity). * **Gold Standard:** Digital Subtraction Angiography (DSA) remains the gold standard for definitive vascular mapping and preoperative embolization. * **Clinical Presentation:** Pulsatile tinnitus and conductive hearing loss are the most common presenting symptoms. * **Phelps Sign:** Loss of the bony plate between the carotid canal and the jugular fossa seen on CT.
Explanation: ### Explanation **Correct Answer: B. Aortic dissection** **Why it is correct:** In interventional radiology, endovascular aortic repair (EVAR) or thoracic endovascular aortic repair (TEVAR) using stents is a primary treatment modality for **Aortic Dissection**, particularly **Stanford Type B** dissections that are complicated (e.g., malperfusion syndrome, impending rupture, or persistent pain). The stent-graft serves to cover the primary intimal tear, redirecting blood flow into the true lumen and promoting thrombosis of the false lumen, thereby preventing aneurysmal expansion or rupture. **Analysis of Incorrect Options:** * **A. Acute aortic occlusion:** This is a surgical emergency often caused by a saddle embolus at the aortic bifurcation (Leriche syndrome). While catheter-directed thrombolysis or thrombectomy may be used, the primary management is usually surgical embolectomy (Fogarty catheter) rather than routine stenting. * **C. Rheumatic aortitis:** Rheumatic fever primarily affects the heart valves (mitral/aortic). While "aortitis" can occur in conditions like Takayasu arteritis or Syphilis, it is not a feature of Rheumatic heart disease. Inflammatory aortitis is managed medically (steroids/immunosuppressants) rather than with stents. * **D. Tetralogy of Fallot (ToF):** ToF is a congenital cyanotic heart disease characterized by VSD, pulmonary stenosis, overriding aorta, and RV hypertrophy. Treatment is surgical repair (Blalock-Taussig shunt or total correction), not aortic stenting. **High-Yield Clinical Pearls for NEET-PG:** * **Stanford Classification:** Type A involves the ascending aorta (Surgical emergency); Type B involves the descending aorta distal to the left subclavian artery (Medical/Endovascular management). * **Gold Standard Investigation:** For acute aortic dissection, **CT Angiography (CTA)** is the investigation of choice. * **TEVAR:** The primary goal of stenting in dissection is to "seal the entry tear." * **Coarctation of Aorta:** Another high-yield indication for aortic stenting in adults is post-ductal coarctation.
Explanation: **Explanation:** **TIPS (Transjugular Intrahepatic Portosystemic Shunt)** is a percutaneous interventional procedure used primarily to manage complications of portal hypertension, such as refractory ascites and variceal bleeding. 1. **Why Option B is Correct:** The procedure involves gaining access via the **Internal Jugular Vein**, advancing a catheter through the Superior Vena Cava and Inferior Vena Cava into the **Hepatic Vein**. From there, a needle is used to puncture through the liver parenchyma to reach a branch of the **Portal Vein**. A stent is then deployed to create a low-resistance channel between these two systems, effectively shunting blood from the high-pressure portal circulation directly into the systemic circulation, bypassing the cirrhotic liver. 2. **Why Other Options are Incorrect:** * **Option A:** While the shunt eventually drains into the vena cava, the physical tract is created specifically between the portal and hepatic veins within the liver substance. * **Option C:** This describes the normal physiological drainage of the liver; no artificial shunt is needed here. * **Option D:** The hepatic artery carries oxygenated blood to the liver; shunting portal blood into it would not decompress the portal system. **High-Yield Clinical Pearls for NEET-PG:** * **Indications:** Refractory variceal bleeding (most common), refractory ascites, and Budd-Chiari syndrome. * **Contraindications:** Severe congestive heart failure (due to sudden increase in venous return), severe pulmonary hypertension, and multiple hepatic cysts. * **Major Complication:** **Hepatic Encephalopathy** (due to decreased detoxification of ammonia) and shunt stenosis. * **Goal:** To reduce the Portosystemic Pressure Gradient (PPG) to **<12 mmHg**.
Explanation: **Explanation:** The goal of in situ ablation is to destroy tumor tissue (liver secondaries) directly within the organ using thermal, chemical, or electrical energy. **Why Ultrasonic Waves is the Correct Answer:** Diagnostic **ultrasonic waves** (Ultrasound) are used for **imaging and guidance** during ablation procedures, but they do not possess the energy density required to destroy tissue in situ. While a specific technology called HIFU (High-Intensity Focused Ultrasound) exists, standard ultrasonic waves are non-invasive imaging tools, not an ablative modality themselves. Therefore, it is the "except" in this list. **Analysis of Other Options:** * **Alcohol (Chemical Ablation):** Percutaneous Ethanol Injection (PEI) involves injecting absolute alcohol into the lesion, causing immediate protein denaturation and cellular dehydration, leading to coagulative necrosis. It is highly effective for small hepatocellular carcinomas and some secondaries. * **Radiofrequency Ablation (RFA):** This is the most common thermal ablation technique. It uses high-frequency alternating current to generate frictional heat (60°C–100°C), causing thermal coagulation and tissue death. * **Cryotherapy (Cryoablation):** This involves the use of a cryoprobe (using liquid nitrogen or argon gas) to freeze the tumor tissue to temperatures as low as -40°C. The formation of intracellular ice crystals leads to cell membrane disruption and vascular stasis. **Clinical Pearls for NEET-PG:** * **Gold Standard for Small HCC:** RFA is generally preferred over PEI for lesions >2 cm due to better local control. * **Microwave Ablation (MWA):** A newer thermal modality that is faster than RFA and less affected by the "heat-sink effect" (cooling by adjacent large blood vessels). * **Indication:** Ablation is typically indicated for patients with limited liver secondaries (usually <3-5 lesions, <3 cm each) who are not candidates for surgical resection.
Explanation: **Explanation:** The **Transjugular Intrahepatic Portosystemic Shunt (TIPS)** is a procedure used to manage complications of portal hypertension (e.g., refractory ascites, variceal bleeding) by creating a low-resistance channel between the portal vein and the hepatic vein. **Why Encephalopathy is the correct answer:** Hepatic Encephalopathy (HE) is the most frequent complication, occurring in **25–45%** of patients. By creating a shunt, blood bypasses the liver’s detoxification process. Neurotoxic substances (primarily ammonia) enter the systemic circulation directly, leading to cognitive impairment and altered consciousness. Risk factors include older age, pre-existing HE, and a high MELD score. **Analysis of Incorrect Options:** * **Hepatic Ischemia:** While the liver loses some portal venous inflow after TIPS, the increased compensatory flow from the hepatic artery usually prevents significant ischemia. It is a rare complication. * **Infection:** "Sepsis" or "Endoleaks" (infection of the stent) can occur but are uncommon due to sterile techniques and prophylactic antibiotics. * **Life-threatening hemorrhage:** While intraperitoneal hemorrhage is a feared acute complication (due to accidental puncture of the liver capsule), it occurs in less than 1–2% of cases, making it far less common than encephalopathy. **High-Yield Clinical Pearls for NEET-PG:** * **Primary Indication:** Secondary prophylaxis of variceal bleeding and refractory ascites. * **Absolute Contraindications:** Severe congestive heart failure (due to sudden increase in venous return), polycystic liver disease, and severe uncontrolled systemic infection. * **Monitoring:** Doppler Ultrasound is the first-line investigation to check for shunt patency or stenosis. * **Management of HE post-TIPS:** Usually managed medically (Lactulose/Rifaximin); if refractory, the shunt diameter may need to be reduced.
Explanation: **Explanation:** **Transjugular Intrahepatic Portosystemic Shunt (TIPS)** is a procedure used to reduce portal hypertension by creating a low-resistance channel between the portal vein and the hepatic vein. **Why Hepatopulmonary Syndrome (HPS) is the correct answer:** Hepatopulmonary syndrome is characterized by a triad of liver disease, increased alveolar-arterial oxygen gradient, and **intrapulmonary vascular dilatations**. Performing a TIPS can actually **worsen** HPS because the shunt allows more blood to bypass the liver, potentially increasing the delivery of vasodilators to the pulmonary circulation, thereby exacerbating the ventilation-perfusion mismatch and hypoxemia. Therefore, HPS is generally considered a relative contraindication rather than an indication. **Why the other options are incorrect:** * **Prevention of acute variceal bleed:** TIPS is indicated for secondary prophylaxis of variceal bleeding when endoscopic or pharmacological treatments fail (Refractory bleeding). * **Hepatorenal syndrome (HRS):** TIPS can improve renal perfusion and function in patients with Type 1 and Type 2 HRS by reducing the portal pressure that triggers systemic vasodilation. * **Refractory ascites:** This is a classic indication. By reducing portal pressure, TIPS decreases the formation of ascitic fluid and improves the response to diuretics. **High-Yield Clinical Pearls for NEET-PG:** * **Absolute Contraindications for TIPS:** Congestive heart failure (due to sudden increase in venous return), severe pulmonary hypertension, and polycystic liver disease. * **Most common complication:** Hepatic encephalopathy (due to bypass of nitrogenous toxins). * **Preferred Stent:** PTFE-covered stents (Gore-Tex) are preferred over bare metal stents as they have higher patency rates. * **Goal of TIPS:** To reduce the Portosystemic Pressure Gradient (PPG) to **<12 mmHg**.
Explanation: **Explanation:** **TIPS (Transjugular Intrahepatic Portosystemic Shunt)** is a high-yield interventional radiology procedure used primarily to manage complications of portal hypertension, such as refractory ascites and variceal bleeding. **Why Option B is Correct:** TIPS involves creating an artificial channel within the liver parenchyma to connect the **portal vein** (high pressure) to the **hepatic vein** (low pressure). Because this tract is created entirely within the liver tissue using a metallic stent, it is classified as an **intrahepatic shunt**. **Analysis of Incorrect Options:** * **Option A:** TIPS is a **Portosystemic** shunt, specifically a side-to-side **Porto-Hepatic** shunt. A "Portacaval" shunt specifically refers to a connection between the portal vein and the Inferior Vena Cava (IVC), which is typically a surgical procedure. * **Option C:** It is a **radiological procedure**, not endoscopic. It is performed under fluoroscopic guidance by an Interventional Radiologist, usually via the **Right Internal Jugular Vein**. * **Option D:** While TIPS can be used as a "bridge" to transplantation, it is **not** the "most suitable" for these patients compared to other options, as the stent can technically complicate the subsequent transplant surgery. Furthermore, it is contraindicated in patients with severe heart failure or polycystic liver disease. **High-Yield Clinical Pearls for NEET-PG:** * **Access Route:** Right Internal Jugular Vein → SVC → IVC → Right Hepatic Vein → Liver Parenchyma → Portal Vein. * **Indications:** Refractory ascites (most common), recurrent variceal bleed, Budd-Chiari syndrome. * **Absolute Contraindications:** Severe Right-sided Heart Failure (due to sudden increase in venous return), Polycystic Liver Disease, and Severe Hepatic Encephalopathy. * **Major Complication:** New-onset or worsening **Hepatic Encephalopathy** (due to bypass of detoxification).
Explanation: **Explanation:** The detection of gastrointestinal (GI) bleeding depends significantly on the sensitivity of the diagnostic modality used. **Conventional Angiography** (Catheter Angiography) requires an active bleeding rate of at least **0.5 ml/min** to visualize the extravasation of contrast into the bowel lumen. This is considered the "gold standard" for localization when therapeutic intervention (like embolization) is planned, but it requires the patient to be bleeding actively during the procedure. **Analysis of Options:** * **0.5 ml/min (Correct):** This is the established threshold for conventional angiography. It is less sensitive than nuclear medicine but more specific for anatomical localization. * **0.1 ml/min (Incorrect):** This is the sensitivity threshold for **Technetium-99m (Tc-99m) tagged RBC scintigraphy**. Nuclear scans are the most sensitive non-invasive tests for GI bleeds, capable of detecting rates as low as 0.1–0.4 ml/min. * **0.3 - 0.5 ml/min (Context):** **Multidetector CT Angiography (MDCTA)** typically detects bleeding at rates of 0.3–0.5 ml/min, making it slightly more sensitive than conventional angiography in some clinical settings. * **2 ml/min and 5 ml/min (Incorrect):** These rates are well above the detection limits of modern imaging and would represent brisk, massive hemorrhages easily seen on any vascular study. **High-Yield Clinical Pearls for NEET-PG:** * **Order of Sensitivity:** Tagged RBC Scan (0.1 ml/min) > CTA (0.3-0.5 ml/min) > Conventional Angiography (0.5 ml/min). * **Advantage of Angiography:** It allows for immediate therapeutic intervention (e.g., coiling or Gelfoam embolization). * **Prerequisite:** For a positive angiogram, the bleed must be **active** at the time of contrast injection. * **First-line for unstable patients:** CTA is often the initial investigation of choice due to speed and high sensitivity.
Explanation: **Explanation:** In cerebral angiography, the **Femoral artery** (specifically the common femoral artery) is the most common site for percutaneous arterial access. This approach is known as the **Seldinger technique**. **Why Femoral Artery is the Correct Choice:** The femoral artery is the preferred route because it is a large-caliber, superficial vessel that is easily compressible against the femoral head to achieve hemostasis. Its relatively straight course through the aorta provides a direct and stable pathway for navigating catheters into the carotid and vertebral arteries. This allows for the use of larger catheters and complex interventional devices if needed. **Analysis of Incorrect Options:** * **Brachial and Axillary Arteries:** These were used more frequently in the past. However, they are associated with a higher risk of neurovascular complications (e.g., brachial plexus injury) and are more difficult to compress, leading to a higher risk of hematoma. * **Radial Artery:** While the transradial approach is gaining popularity (especially in cardiology and increasingly in neuro-interventions) due to lower site-related bleeding risks and earlier patient mobilization, the **femoral artery remains the traditional "gold standard" and the most common answer expected in standard examinations.** **High-Yield Clinical Pearls for NEET-PG:** * **Seldinger Technique:** The universal method for vascular access (Needle → Guide wire → Dilator/Sheath → Catheter). * **Access Site:** The puncture is made below the inguinal ligament to avoid retroperitoneal hemorrhage. * **Gold Standard:** Digital Subtraction Angiography (DSA) via the femoral route remains the gold standard for diagnosing cerebral aneurysms and Arteriovenous Malformations (AVMs).
Explanation: **Explanation:** **TIPS (Transjugular Intrahepatic Portosystemic Shunt)** is a procedure used to manage complications of portal hypertension (e.g., refractory ascites, variceal bleeding) by creating a low-resistance channel between the portal vein and the hepatic vein. **Why Encephalopathy is the correct answer:** Hepatic Encephalopathy (HE) is the most common **early** complication, occurring in approximately 25–40% of patients. By creating a shunt, blood bypasses the liver's detoxification process, allowing nitrogenous wastes (like ammonia) to enter the systemic circulation directly. This typically manifests within the first few weeks post-procedure. **Analysis of Incorrect Options:** * **A. Shunt Stenosis:** This is a **late** complication (months to years later), usually caused by pseudointimal hyperplasia within the stent. * **B. Capsular Hemorrhage:** This is an **immediate/procedural** complication caused by accidental puncture of the liver capsule during the needle pass from the hepatic vein to the portal vein. While it occurs early, it is less frequent than encephalopathy in the post-procedural period. * **C. Recurrent Variceal Bleed:** This is generally a sign of **shunt failure or occlusion** (a late complication) rather than an expected early side effect of a functioning shunt. **High-Yield Clinical Pearls for NEET-PG:** * **Indications:** Secondary prophylaxis for variceal bleed, refractory ascites, and Budd-Chiari syndrome. * **Contraindications:** Absolute contraindications include severe congestive heart failure (due to sudden increase in venous return), polycystic liver disease, and severe active systemic infection. * **Monitoring:** Doppler Ultrasound is the primary modality used to monitor shunt patency. * **MELD Score:** A high MELD score (>18) is a predictor of poor prognosis post-TIPS.
Explanation: **Explanation:** **Uterine Artery Embolization (UAE)** is a minimally invasive interventional radiology procedure used to occlude the blood supply to the uterus or specific lesions within it. **Why Option D is Correct:** **Endometriosis** is characterized by the presence of endometrial-like tissue outside the uterus (e.g., ovaries, peritoneum). Since these ectopic implants are scattered and derive blood supply from various systemic and pelvic vessels, localized uterine artery embolization is **not an indicated or effective treatment** for preventing bleeding in endometriosis. Medical management (hormonal therapy) or surgical excision remains the standard of care. **Why Incorrect Options are Wrong:** * **A. Uterine Arteriovenous Malformation (AVM):** UAE is the treatment of choice for symptomatic AVMs to prevent life-threatening hemorrhage while preserving fertility. * **B. Postpartum Hemorrhage (PPH):** UAE is a critical emergency intervention for refractory PPH (especially after failed medical management or uterine atony) in hemodynamically stable patients. * **C. Bleeding Fibroid:** Uterine Fibroid Embolization (UFE) is a well-established indication to reduce the size of the fibroid and control menorrhagia. **High-Yield Clinical Pearls for NEET-PG:** * **Access:** Usually performed via the **Common Femoral Artery** (CFA) or Radial Artery. * **Embolic Agents:** Most commonly used are **Polyvinyl Alcohol (PVA) particles** or Tris-acryl gelatin microspheres. * **Contraindications:** Pregnancy, active pelvic infection, and suspected uterine malignancy. * **Post-Procedure:** "Post-embolization syndrome" (pain, low-grade fever, nausea) is the most common complication.
Explanation: **Explanation:** **Transjugular Intrahepatic Portosystemic Shunt (TIPS)** is a procedure used to manage complications of portal hypertension by creating a low-resistance channel between the portal vein and the hepatic vein. **Why Option B is Correct:** **Capsule rupture and intraperitoneal hemorrhage** is a dreaded **early/acute complication** that occurs during the procedure. It happens if the needle used to puncture the portal vein from the hepatic vein passes through the liver parenchyma and inadvertently pierces the liver capsule (Glisson’s capsule). This leads to immediate hemoperitoneum and can be life-threatening. **Analysis of Incorrect Options:** * **A. Hepatic Encephalopathy:** While a common complication (occurring in ~25-30% of patients), it is typically considered a **subacute to chronic** complication. It occurs because the shunt allows unfiltered nitrogenous waste (like ammonia) to bypass the liver and enter the systemic circulation. * **C. Stenosis of the Shunt:** This is a **late complication**, usually occurring months after the procedure due to pseudointimal hyperplasia within the stent. * **D. Thrombosis of the Shunt:** This can occur early or late, but it is less common than bleeding complications during the initial periprocedural period. **High-Yield Clinical Pearls for NEET-PG:** * **Indications:** Refractory ascites and variceal bleeding unresponsive to endoscopic therapy. * **Absolute Contraindications:** Severe congestive heart failure (due to sudden increase in venous return), polycystic liver disease, and severe uncontrolled systemic infection. * **Monitoring:** Doppler Ultrasound is the primary modality used to monitor shunt patency. * **Goal:** To reduce the Portosystemic Pressure Gradient (PPG) to **<12 mmHg**.
Explanation: **Explanation:** The **Seldinger technique**, named after Swedish radiologist Sven-Ivar Seldinger, is the gold standard method for obtaining safe percutaneous access to hollow organs or blood vessels. **Why Arteriography is correct:** Arteriography (and most endovascular procedures) requires the insertion of a catheter into a blood vessel. The Seldinger needle is the initial tool used to puncture the vessel. Once blood flashback is observed, a **guidewire** is passed through the needle, the needle is withdrawn, and a **sheath or catheter** is then advanced over the wire. This "over-the-wire" method minimizes trauma to the vessel wall and prevents bleeding, making it the foundation of interventional radiology. **Why other options are incorrect:** * **Liver Biopsy:** Typically performed using specialized biopsy needles like the **Tru-Cut** or **Menghini** needle, which are designed to capture a core of tissue rather than provide a channel for a wire. * **Suturing Skin:** This requires surgical needles (curved or straight) attached to suture material, not a hollow-bore Seldinger needle. * **Lymphography:** This historical procedure involves the direct cannulation of a lymphatic vessel (usually on the foot) using a very fine, small-gauge needle or cannula after injecting blue dye to visualize the lymphatics. **High-Yield Clinical Pearls for NEET-PG:** * **Modified Seldinger Technique:** Used for venous access (e.g., Central Lines, PICC lines). * **Components of a Seldinger Kit:** Hollow needle, guidewire (often J-tipped), dilator, and catheter/sheath. * **Complications:** The most common complication of the Seldinger technique is **hematoma** at the puncture site. * **Key Step:** Always remember to "never advance the wire against resistance" to avoid vessel dissection or perforation.
Explanation: **Explanation:** Therapeutic embolization involves the intentional occlusion of a blood vessel using various agents to control hemorrhage, devascularize tumors, or treat vascular malformations. **Why Omentum is the correct answer:** The **Omentum** is a large, fatty fold of peritoneal tissue. While it is highly vascular and used in "omental transposition" surgeries to promote healing or provide a blood supply to ischemic areas, it is **not** an embolic agent. It cannot be injected or delivered through a catheter into a vessel to cause occlusion. **Analysis of incorrect options:** * **Blood Clot:** This is a **temporary** embolic agent. Autologous blood clots were among the first materials used for embolization. They are eventually lysed by the body’s fibrinolytic system, making them useful when only short-term occlusion is required. * **Ethyl Alcohol (Absolute Alcohol):** This is a **permanent** liquid sclerosing agent. It causes rapid protein denaturation and endothelial destruction, leading to total and permanent vascular occlusion. It is commonly used for arteriovenous malformations (AVMs) and renal ablation. * **Wool:** While less common today, wool (specifically **Dacron or cotton fibers** attached to stainless steel coils) is used to increase the thrombogenicity of the device. The fibers induce rapid local thrombosis to ensure complete vessel occlusion. **High-Yield Clinical Pearls for NEET-PG:** * **Classification of Embolic Agents:** * **Temporary:** Gelfoam (absorbable gelatin sponge), Autologous blood clot. * **Permanent:** Coils (Stainless steel/Platinum), PVA (Polyvinyl Alcohol) particles, Cyanoacrylate (Glue), and Absolute Alcohol. * **Gelfoam** is the most commonly used temporary agent (lasts 2–6 weeks). * **Absolute Alcohol** is the most potent and carries a higher risk of tissue necrosis if it refluxes into non-target vessels.
Explanation: **Explanation:** **Carotid-Cavernous Fistula (CCF)** is an abnormal communication between the carotid arterial system and the cavernous sinus. It is categorized into Direct (high-flow, usually traumatic) and Indirect (low-flow, spontaneous). **Why Option A is Correct:** **Endovascular embolization** is the current gold standard and most commonly employed treatment. Specifically, **detachable balloon embolization** is the preferred technique for direct CCFs. The goal is to navigate a balloon into the cavernous sinus via the internal carotid artery (ICA) and inflate it to seal the fistula while maintaining the patency of the ICA. If balloons are unavailable or technically difficult, **platinum coils** or liquid embolic agents (like Onyx) are used. **Why Other Options are Incorrect:** * **Option B (Ligation of ICA):** This was a historical surgical approach. It is rarely performed now because it carries a high risk of ischemic stroke and does not always close the fistula due to collateral flow. * **Option C (No treatment available):** This is incorrect. Untreated CCFs can lead to progressive vision loss, intracranial hemorrhage, and debilitating proptosis. * **Option D (Fistulectomy):** Direct surgical excision (fistulectomy) of a CCF is technically extremely difficult and hazardous due to the complex anatomy of the cavernous sinus and the risk of massive hemorrhage. **Clinical Pearls for NEET-PG:** * **Classic Triad:** Pulsatile exophthalmos (proptosis), conjunctival chemosis, and an orbital bruit. * **Gold Standard Investigation:** Digital Subtraction Angiography (DSA) is the definitive diagnostic tool to characterize the fistula. * **Classification:** The **Barrow Classification** divides CCFs into Types A (Direct), and B, C, D (Indirect/Dural). * **Treatment Goal:** To occlude the fistula while preserving the parent artery (ICA).
Explanation: **Explanation:** **TIPS (Transjugular Intrahepatic Portosystemic Shunt)** is a procedure used to manage complications of portal hypertension (like refractory ascites and variceal bleeding). It involves creating an artificial channel within the liver, using a stent, to connect the **portal vein** (high pressure) directly to the **hepatic vein** (low pressure). 1. **Why it is a Non-selective Shunt (Correct):** A shunt is "non-selective" if it diverts the **entire** portal venous flow away from the liver and into the systemic circulation. TIPS acts as a total shunt because it decompresses the entire portal venous system indiscriminately. This reduces portal pressure effectively but increases the risk of hepatic encephalopathy because toxic metabolites (like ammonia) bypass the liver's detoxification process entirely. 2. **Why other options are incorrect:** * **Selective Shunt:** These shunts (e.g., **Distal Splenorenal Shunt/Warren Shunt**) divert only a portion of the portal flow (specifically from the gastroesophageal varices via the splenic vein) while maintaining portal blood flow to the liver (prograde flow). This preserves liver function better than TIPS. * **Systemic Shunt:** While TIPS connects the portal to the systemic system, the term "systemic shunt" is too broad. In the context of portal hypertension classification, the distinction between "selective" and "non-selective" is the standard nomenclature. **High-Yield Clinical Pearls for NEET-PG:** * **Route:** Internal Jugular Vein → Superior Vena Cava → Right Atrium → Inferior Vena Cava → Hepatic Vein → Portal Vein. * **Indications:** Secondary prophylaxis of variceal bleed, refractory ascites, Budd-Chiari syndrome, and Hepatorenal syndrome. * **Absolute Contraindications:** Severe congestive heart failure (due to sudden increase in preload), severe pulmonary hypertension, and multiple hepatic cysts/polycystic liver disease. * **Most Common Complication:** Hepatic Encephalopathy (due to bypass of nitrogenous waste).
Explanation: **Explanation:** **Correct Answer: C. Charles Dotter** Charles Dotter is widely recognized as the **"Father of Interventional Radiology."** In 1964, he performed the first percutaneous transluminal angioplasty (PTA) by using a series of catheters to dilate a stenosed superficial femoral artery in an elderly patient, successfully avoiding an amputation. He famously advocated for the "catheter as a surgical tool," shifting radiology from a purely diagnostic field to a therapeutic one. **Analysis of Incorrect Options:** * **A. Henry Becquerel:** A physicist who discovered **spontaneous radioactivity** (alongside the Curies). He is not associated with interventional procedures. * **B. Marie Curie:** Renowned for her pioneering research on **radioactivity** and the discovery of Polonium and Radium. While she advanced medical X-rays during WWI, she did not develop interventional techniques. * **D. W.C. Roentgen:** Discovered **X-rays** in 1895. He is considered the "Father of Diagnostic Radiology," but not Interventional Radiology. **High-Yield Clinical Pearls for NEET-PG:** * **Seldinger Technique:** Developed by Sven-Ivar Seldinger (1953), this is the fundamental method for gaining vascular access using a needle, guidewire, and sheath. * **Andreas Gruentzig:** He expanded on Dotter’s work by developing the first **balloon catheter**, leading to modern coronary angioplasty. * **Image Guidance:** Interventional Radiology (IR) utilizes Fluoroscopy, CT, and Ultrasound to perform minimally invasive procedures like embolization, biopsies, and drainage.
Explanation: **Explanation:** The **Seldinger technique**, described by Sven-Ivar Seldinger in 1953, is the gold standard method for obtaining percutaneous access to hollow organs or blood vessels. The **Seldinger needle** is a hollow, large-bore needle used as the initial step to puncture a vessel (most commonly the femoral artery). Once blood flashback is observed, a guide wire is inserted through the needle, the needle is withdrawn, and a catheter is advanced over the wire. This makes it the fundamental tool for **Arteriography** and other endovascular procedures. **Analysis of Options:** * **B. Arteriography (Correct):** It is the primary application. The technique allows for safe, large-bore catheterization of arteries for diagnostic imaging or therapeutic interventions (like stenting). * **A. Suturing muscles:** Seldinger needles are rigid and hollow, designed for vascular access, not for passing suture material through muscular tissue. * **C. Pulmonary biopsy:** While some percutaneous biopsies use coaxial systems, a standard Seldinger needle is specifically designed for vascular entry, not for harvesting tissue cores from the lung. * **D. Lymphangiography:** This procedure typically requires direct surgical cut-down and cannulation of a lymphatic vessel using a very fine-gauge needle or cannula, as lymphatics are too small and low-pressure for the standard Seldinger technique. **High-Yield Clinical Pearls for NEET-PG:** * **Steps of Seldinger Technique:** Puncture → Guidewire insertion → Needle removal → Dilatation (optional) → Catheter insertion over the wire. * **Modified Seldinger Technique:** Uses a needle with a stylet (to prevent tissue plugging) or a "single-wall" puncture to reduce hematoma risk. * **Common Sites:** Common Femoral Artery (most common), Radial Artery, and Internal Jugular Vein (for Central Venous Lines). * **Complications:** Hematoma, pseudoaneurysm, and arterial dissection.
Explanation: **Explanation:** **TIPS (Transjugular Intrahepatic Portosystemic Shunt)** is a high-yield interventional radiology procedure used primarily to treat complications of portal hypertension, such as refractory ascites and variceal bleeding. **Why Option C is Correct:** The procedure involves creating an artificial channel within the liver parenchyma that connects the **Portal Vein** (high-pressure system) to the **Hepatic Vein** (low-pressure system). By bypassing the congested liver sinusoidal bed, the portal venous pressure is effectively decompressed as blood flows directly into the systemic circulation via the Inferior Vena Cava (IVC). **Analysis of Incorrect Options:** * **Option A & D:** The **Hepatic Artery** supplies oxygenated blood to the liver. Connecting it to the portal or hepatic veins would create an arteriovenous fistula, which does not address portal hypertension and could lead to high-output heart failure. * **Option B:** While the goal is to reach the systemic circulation, the shunt is anatomically created between the portal vein and the hepatic vein (usually the right hepatic vein). A direct portal vein to **IVC** shunt is a surgical procedure (Portacaval shunt), not the standard radiologic TIPS. **NEET-PG High-Yield Pearls:** * **Access Route:** Internal Jugular Vein (usually the right side) → Superior Vena Cava → Right Atrium → IVC → Hepatic Vein. * **Indications:** Refractory variceal bleeding (most common), refractory ascites, and Budd-Chiari syndrome. * **Contraindications:** Severe congestive heart failure (due to sudden increase in venous return), severe pulmonary hypertension, and multiple hepatic cysts. * **Major Complication:** **Hepatic Encephalopathy** (due to nitrogenous wastes bypassing liver detoxification) and shunt stenosis.
Explanation: **Explanation:** Uterine Artery Embolization (UAE) is a minimally invasive interventional radiology procedure that involves the occlusion of the uterine arteries using embolic agents (such as polyvinyl alcohol particles or coils). The primary goal is to devascularize targeted pathology while preserving the uterus. **Why "All of the Above" is Correct:** * **Large Fibroids (Option A):** UAE is a well-established alternative to hysterectomy or myomectomy. By cutting off the blood supply, the fibroids undergo ischemic necrosis and shrink, significantly reducing symptoms like menorrhagia and pelvic pressure. * **Uterine Arteriovenous Malformation (Option B):** AVMs are abnormal communications between arteries and veins. UAE is the **treatment of choice** for symptomatic AVMs, as it allows for targeted occlusion of the nidus, preventing life-threatening hemorrhage. * **Intractable Uterine Bleeding (Option C):** UAE is a critical emergency intervention for severe postpartum hemorrhage (PPH) or bleeding secondary to malignancy when conservative measures fail and the patient is hemodynamically stable enough for the procedure. **Clinical Pearls for NEET-PG:** * **Access Site:** Usually the common femoral artery (unilateral or bilateral approach). * **Contraindications:** Pregnancy, active pelvic infection, and suspected uterine malignancy (relative). * **Post-Embolization Syndrome:** The most common complication, characterized by pain, low-grade fever, and nausea due to tissue ischemia. * **High-Yield Fact:** For fibroids, UAE is specifically indicated for those who wish to avoid surgery but may not be the first choice for those desiring future fertility (though it is not an absolute contraindication).
Explanation: **Explanation:** Uterine Artery Embolization (UAE) is a minimally invasive procedure primarily used for the management of symptomatic uterine fibroids and adenomyosis. Understanding the contraindications is high-yield for NEET-PG. **Why Option D is the Correct Answer:** **Age ≥ 50 years** is **not** a contraindication. While UAE is often preferred by women wishing to preserve their uterus or avoid major surgery in their 30s and 40s, there is no upper age limit for the procedure. In perimenopausal women (around age 50), UAE can effectively bridge the gap to natural menopause by resolving symptoms like menorrhagia. **Analysis of Incorrect Options (Absolute Contraindications):** * **A. Pregnancy:** UAE is strictly contraindicated as it can lead to placental insufficiency, fetal growth restriction, or fetal demise due to compromised uterine blood flow. * **B. Uterine Infection:** Active pelvic inflammatory disease (PID) or uterine sepsis is an absolute contraindication. Embolizing an infected organ can lead to abscess formation, necrosis, and septic shock. * **C. Endometrial Cancer:** UAE is contraindicated in the presence of suspected or confirmed gynecological malignancy (endometrial, cervical, or uterine sarcoma). These conditions require definitive surgical staging and oncological management; embolization may delay diagnosis or mask symptoms. **Clinical Pearls for NEET-PG:** * **Most common indication:** Symptomatic uterine fibroids (Leiomyomas). * **Agent of choice:** Polyvinyl Alcohol (PVA) particles or Tris-acryl gelatin microspheres. * **Post-Embolization Syndrome:** The most common complication, characterized by pain, low-grade fever, nausea, and leukocytosis (managed conservatively). * **Relative Contraindications:** Renal insufficiency (due to contrast), uncorrected coagulopathy, and prior pelvic radiation.
Explanation: **Explanation:** Embolization is an interventional radiology procedure where substances are introduced into the circulatory system to deliberately occlude a blood vessel. This is used to stop hemorrhage, devascularize tumors, or treat aneurysms and arteriovenous malformations (AVMs). The correct answer is **D (All of the above)** because embolization agents are classified based on their duration of action, and all three options represent different categories: 1. **Gelfoam (Absorbable Gelatin Sponge):** A **temporary** particulate agent. It provides occlusion for roughly 2 to 6 weeks before being resorbed. It is commonly used in trauma or preoperative embolization where permanent occlusion is not required. 2. **Polyvinyl Alcohol (PVA):** A **permanent** particulate agent. These non-absorbable particles cause inflammatory endarteritis leading to permanent vascular occlusion. They are frequently used for uterine artery embolization (fibroids) and bronchial artery embolization. 3. **Autologous Blood Clot:** A **temporary** agent (the shortest acting). While rarely used today due to rapid lysis (within hours), it was historically the first embolic agent used. **High-Yield Facts for NEET-PG:** * **Classification by Duration:** * *Temporary:* Gelfoam, Autologous blood clot, Oxidized cellulose. * *Permanent:* PVA, Coils (mechanical), Glue (Cyanoacrylate), Onyx (Ethylene vinyl alcohol copolymer), Absolute Alcohol (Sclerosant). * **Absolute Alcohol:** Considered the most potent and permanent embolic agent; it causes immediate protein denaturation and capillary bed destruction. * **Coils:** Best for high-flow vessels (e.g., aneurysms) to induce mechanical thrombosis. * **Onyx:** A liquid embolic agent often used in the treatment of brain AVMs because it solidifies slowly, allowing for controlled delivery.
Explanation: **Explanation:** The **Inferior Mesenteric Artery (IMA)** is the most frequently dissected artery during femoral route arteriography due to its unique anatomical orientation and small caliber. **Why the IMA is the correct answer:** 1. **Anatomical Angle:** The IMA originates from the anterolateral aspect of the abdominal aorta at an acute, downward angle (around the L3 level). When advancing catheters or guide wires superiorly from the femoral artery, the tip often inadvertently enters the IMA orifice. 2. **Vessel Size:** Compared to the Celiac trunk or SMA, the IMA has a significantly smaller diameter. This makes it more prone to intimal injury and subsequent dissection when a standard-sized catheter is manipulated near its origin. 3. **Catheter Mechanics:** During retrograde femoral access, the "hooking" motion used to select visceral vessels often puts undue stress on the IMA's ostium if the catheter is not carefully managed. **Analysis of Incorrect Options:** * **Celiac Trunk (A) & Superior Mesenteric Artery (B):** These are much larger vessels with higher flow rates. While they are frequently catheterized, their larger diameter makes them more resilient to mechanical dissection compared to the IMA. * **Gastroduodenal Artery (D):** This is a branch of the common hepatic artery. It is a distal target rather than a primary aortic branch encountered during the initial ascent of the catheter, making it a less common site for primary iatrogenic dissection during the approach. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site of iatrogenic injury** during abdominal aortography: **IMA**. * **Most common complication of femoral artery puncture:** Hematoma at the puncture site. * **IMA Landmark:** It typically originates 3-4 cm above the aortic bifurcation (at the level of the L3 vertebra). * **Management:** Most iatrogenic dissections are asymptomatic and managed conservatively unless they cause distal ischemia.
Explanation: **Explanation:** Percutaneous Vertebroplasty (PVP) is a minimally invasive procedure involving the injection of bone cement (Polymethylmethacrylate - PMMA) into a vertebral body to provide structural stability and pain relief. **Why Tuberculosis is the Correct Answer (Contraindication):** Active infection, such as **Tuberculous spondylitis (Pott’s spine)** or pyogenic osteomyelitis, is an **absolute contraindication** for vertebroplasty. Injecting foreign material like PMMA into an infected site can exacerbate the infection, prevent effective antibiotic penetration, and lead to the formation of a persistent nidus for bacteria/mycobacteria. Surgical debridement and antitubercular therapy (ATT) are the mainstays of treatment for TB. **Analysis of Incorrect Options (Indications):** * **Osteoporosis:** The most common indication. It is used for painful osteoporotic vertebral compression fractures (VCFs) that do not respond to conservative management. * **Metastasis:** Indicated for painful osteolytic lesions or multiple myeloma to prevent pathological fractures and provide rapid pain relief. * **Hemangioma:** Specifically indicated for symptomatic aggressive vertebral hemangiomas that cause debilitating pain or risk of collapse. **High-Yield Clinical Pearls for NEET-PG:** * **Absolute Contraindications:** Active systemic or local infection, uncorrected coagulopathy, and asymptomatic fractures. * **Relative Contraindication:** Retropulsion of a bone fragment into the spinal canal (risk of cord compression). * **Kyphoplasty vs. Vertebroplasty:** Kyphoplasty involves inflating a balloon first to restore vertebral height before injecting cement, whereas vertebroplasty is a high-pressure injection without height restoration. * **Most common complication:** Cement leakage (usually asymptomatic, but can cause pulmonary embolism or nerve root compression).
Explanation: **Explanation:** **Tolazoline** is a non-selective **alpha-adrenergic receptor antagonist** (alpha-blocker) that acts as a potent direct peripheral **vasodilator**. In the context of interventional radiology and cardiology, it is primarily used to counteract vasospasm and improve blood flow. **Why Option B is Correct:** During angiographic procedures, mechanical irritation from catheters or wires can trigger arterial spasms. Tolazoline is administered intra-arterially to induce vasodilation, particularly in coronary or peripheral vessels, to improve visualization of the distal vasculature and facilitate the passage of interventional tools. **Analysis of Incorrect Options:** * **Option A:** Thrombin inhibitors (like Heparin or Bivalirudin) are anticoagulants used to prevent clot formation. Tolazoline has no effect on the coagulation cascade. * **Option C:** Vasoconstrictors (like Vasopressin or Terlipressin) are used to treat variceal bleeding by reducing portal pressure. Tolazoline, being a vasodilator, would be contraindicated as it would worsen the condition. * **Option D:** Antispasmodics for biliary or GI spasms typically include anticholinergics (like Hyoscine) or Glucagon. Tolazoline acts on vascular smooth muscle rather than the biliary tree. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Competitive alpha-1 and alpha-2 blockade + direct histamine-like effect on vessels. * **Other Uses:** Historically used to treat **Persistent Pulmonary Hypertension of the Newborn (PPHN)**, though largely replaced by Nitric Oxide. * **Angiography Tip:** It is often used in **Superior Mesenteric Artery (SMA) arteriography** to improve the opacification of the portal venous system (indirect portography). * **Side Effects:** Tachycardia (due to alpha-2 blockade) and GI stimulation (increased gastric acid secretion).
Explanation: **Explanation:** **Transarterial Chemoembolization (TACE)** is the standard of care for intermediate-stage Hepatocellular Carcinoma (HCC) (BCLC Stage B). The procedure involves the delivery of a concentrated dose of chemotherapy directly into the hepatic artery supplying the tumor, followed by embolization to induce ischemia and prolong drug retention. **Why Doxorubicin is the Correct Answer:** **Doxorubicin** (an anthracycline) is the most widely used and studied chemotherapeutic agent for TACE. It is highly effective against HCC cells and has a high binding affinity for **Lipiodol** (ethiodized oil), which acts as a carrier. When used in **DEB-TACE** (Drug-Eluting Bead TACE), doxorubicin is loaded into microspheres, allowing for a slow, sustained release that maximizes local tumor necrosis while minimizing systemic toxicity. **Analysis of Incorrect Options:** * **B. Cisplatin:** While used in some protocols (especially in Asia or as part of a "triple-drug cocktail"), it is generally considered a second-line choice compared to doxorubicin due to a higher risk of systemic side effects like nephrotoxicity. * **C. Mitomycin C:** Historically used in combination with other drugs, its use has declined because it is less effective as a monotherapy for HCC compared to doxorubicin. * **D. 5-Fluorouracil:** Primarily used for gastrointestinal malignancies and colorectal liver metastases; it has limited efficacy as a primary agent for HCC in the TACE setting. **High-Yield Clinical Pearls for NEET-PG:** * **Dual Blood Supply:** TACE exploits the fact that HCC receives 90-100% of its blood supply from the **hepatic artery**, while normal liver parenchyma receives 75% from the **portal vein**. * **Lipiodol:** This is a radio-opaque contrast agent that is selectively retained by HCC cells, making it both a drug carrier and a marker for post-procedure imaging. * **Post-Embolization Syndrome:** The most common complication of TACE, characterized by fever, abdominal pain, and nausea/vomiting. * **Contraindication:** TACE is generally contraindicated in patients with **main portal vein thrombosis** (due to risk of liver failure) and Child-Pugh Class C cirrhosis.
Explanation: **Explanation:** Stereotactic Radiosurgery (SRS) is a highly precise form of radiation therapy that delivers a single, high dose of ionizing radiation to a specific target within the brain or spine, while sparing the surrounding healthy tissue. Despite the name, it is a non-invasive procedure and does not involve traditional surgery. **Why "All of the Above" is Correct:** SRS is indicated for various intracranial pathologies where surgical access is difficult or high precision is required: * **Metastatic Brain Tumors (Option A):** SRS is a gold-standard treatment for brain metastases (especially if <3-4 cm in size). It offers excellent local control and is often preferred over whole-brain radiation to avoid cognitive decline. * **Arteriovenous Malformations (AVMs) (Option B):** SRS is used for small-to-medium-sized AVMs, particularly those located in eloquent areas (speech or motor cortex) where surgical resection carries high risk. It induces endothelial proliferation and eventual obliteration of the nidus over 1–3 years. * **Trigeminal Neuralgia (Option C):** It is a recognized treatment for refractory trigeminal neuralgia. The radiation is targeted at the trigeminal nerve root entry zone to disrupt pain signaling. **High-Yield Clinical Pearls for NEET-PG:** * **Modalities:** Common SRS systems include **Gamma Knife** (uses Cobalt-60 sources), **CyberKnife** (robotic linear accelerator), and modified **LINAC** systems. * **Benign Tumors:** SRS is also highly effective for **Acoustic Neuromas** (Vestibular Schwannomas) and **Meningiomas**. * **Dose Gradient:** The hallmark of SRS is a "steep dose fall-off," ensuring that the high-dose zone is strictly confined to the lesion. * **Contraindication:** It is generally not suitable for very large tumors (>3-4 cm) due to the risk of radiation-induced edema in surrounding brain tissue.
Explanation: **Polyvinyl alcohol** - **Polyvinyl alcohol (PVA)** particles are commonly used as embolization material in **uterine artery embolization (UAE)** for fibroids. - These particles create **permanent occlusion** of the small arteries supplying the fibroids, leading to their shrinkage. *Methylene blue* - **Methylene blue** is a dye used for diagnostic purposes (e.g., to identify fistulas) and as an **antiseptic**, not for embolization. - It does not have the physical properties required to achieve arterial occlusion. *Ethacridine lactate* - **Ethacridine lactate** is an **antiseptic** and **abortifacient**, primarily used in second-trimester abortions. - It is not used as an embolization agent for fibroids. *Polyglactin* - **Polyglactin** is a commonly used material for **absorbable sutures** (e.g., Vicryl). - It is designed to be absorbed by the body over time and is not suitable for **permanent arterial occlusion** in embolization procedures.
Explanation: ***Arteriography*** - The **Seldinger technique** involves using a needle to puncture a blood vessel, typically an artery, after which a guidewire is threaded through the needle. - This method is fundamental for inserting catheters for procedures like **arteriography**, which visualizes arteries using contrast. *Breast biopsy* - Breast biopsies typically use specialized biopsy needles (e.g., **core needle biopsy** or vacuum-assisted biopsy needles) designed to extract tissue samples. - These are distinct from the Seldinger needle, which is primarily for accessing blood vessels. *Lymphangiography* - Lymphangiography involves injecting contrast into **lymphatic vessels**, which are typically very fine and superficial. - This procedure usually employs fine-gauge needles or direct cannulation of lymphatic vessels, not the Seldinger needle which is designed for larger vessels. *Liver biopsy* - Liver biopsies are usually performed with a **Menghini needle** or other types of cutting needles that can obtain a core sample from the liver parenchyma. - The Seldinger needle is not designed for obtaining solid tissue biopsies from organs like the liver.
Explanation: ***Bronchial artery embolization*** - **Bronchial artery embolization (BAE)** is the preferred initial treatment for **massive hemoptysis** due to its high success rate and minimally invasive nature. - It works by identifying and occluding the bleeding bronchial arteries, which are the most common source of massive hemoptysis. *Rigid bronchoscopy and Photocoagulation* - **Rigid bronchoscopy** is primarily used for **airway control**, foreign body removal, and occasionally for direct visualization and tamponade in massive hemoptysis. - While **photocoagulation** can be used to treat small bleeds, it is generally ineffective for massive or widespread hemorrhage. *Balloon catheter tamponade* - **Balloon catheter tamponade** can provide temporary control of bleeding by compressing the bleeding site but is not a definitive long-term solution. - It carries risks of tracheal injury and can obstruct the airway, making it a bridging measure until a more definitive treatment can be performed. *Flexible bronchoscopy and cautery* - **Flexible bronchoscopy** is useful for localizing the bleeding site but is **less effective** for controlling massive hemoptysis due to limited suction and instrument channels. - **Cautery** applied through a flexible bronchoscope is generally insufficient for significant bleeding and carries a risk of worsening the hemorrhage.
Explanation: ***Requires active bleeding for detection*** - This is the **major disadvantage** of mesenteric angiography in the setting of GI bleeding. - It requires bleeding at a rate of at least **0.5-1 mL/min** to visualize contrast extravasation, which means it will **miss intermittent or slow bleeding** (the most common pattern in GI hemorrhage). - This significant limitation often makes **CT angiography or nuclear medicine scans** more suitable for detecting slower or intermittent bleeds. - The need for active bleeding at the time of the procedure **directly limits its clinical utility** and is why the study may be negative even when bleeding is ongoing at a slower rate. *It does not identify the specific cause of the bleeding* - While mesenteric angiography primarily localizes the bleeding site rather than identifying the underlying pathology, this is a **secondary limitation**. - The angiographic appearance can sometimes **suggest the etiology** (e.g., vascular malformations show characteristic patterns, tumors may show a blush). - The primary goal of the procedure is **localization for therapeutic intervention**, not definitive diagnosis, so this is less of a disadvantage. *High radiation exposure to patient* - Although mesenteric angiography involves **ionizing radiation**, this is a general concern with fluoroscopy-guided procedures, not its major specific disadvantage in GI bleeding. - The diagnostic and therapeutic benefit typically **outweighs the radiation risk** when active bleeding is appropriately suspected. *Transient ischemic attacks* - This is **not a recognized complication** of mesenteric angiography. - TIAs are **neurological events** related to cerebrovascular circulation, not the mesenteric (abdominal) circulation. - This option is medically inaccurate in the context of mesenteric angiography.
Explanation: ***All of the options*** - **All three agents can be used for tumor embolization** in clinical practice, though they differ in their properties, applications, and duration of effect. - The choice depends on the specific clinical scenario, tumor type, desired duration of occlusion, and available resources. **Polyvinyl alcohol (PVA)** - **Most commonly used particulate embolic agent** with particles ranging from 45-1200 micrometers in size. - Causes **permanent occlusion** as it is non-biodegradable and induces foreign body reaction. - Widely used for **pre-operative embolization** of hypervascular tumors (renal cell carcinoma, meningiomas, bone metastases). - Excellent safety profile with predictable occlusion patterns. **Autologous blood clots** - Can be used for **temporary embolization** as they undergo fibrinolysis and recanalization within days to weeks. - Useful in **emergency situations** or when temporary devascularization is desired. - **Cost-effective option** in resource-limited settings. - Main limitation: unpredictable lysis rate and short duration of effect. **Absolute ethanol** - Potent **sclerosing agent** that causes immediate protein denaturation, endothelial destruction, and vessel thrombosis. - Used for **permanent ablation** in hepatocellular carcinoma (via TACE), renal tumors, and vascular malformations. - Requires **precise delivery technique** due to risks of non-target embolization, severe pain, and potential systemic toxicity. - More technically demanding but highly effective when properly administered.
Explanation: ***Uses alternating current (AC) to generate heat.*** - **Radiofrequency ablation (RFA)** works by delivering a **high-frequency alternating electrical current** (typically 350-500 kHz) through an electrode inserted into the tissue. - This current causes nearby ions to oscillate rapidly, generating **frictional heat** that causes coagulative necrosis and destroys the target tissue. - This is the fundamental **physical principle** underlying all RFA applications. *Separates tissues using heat.* - While heat is generated during RFA, the primary goal is **tissue destruction (ablation)** through thermal coagulation, not mechanical separation. - Tissue separation is more characteristic of electrosurgical cutting tools, which use different waveforms and current densities for dissection. *Operates within the radiofrequency range.* - This statement is technically true, as RFA uses alternating current in the **radiofrequency spectrum** (350-500 kHz). - However, this merely describes a characteristic of the current type and does not explain the **mechanism of action** or how tissue ablation occurs. - This is descriptive, not explanatory of the principle. *Destroys nerve tissue for pain relief.* - This describes a **specific clinical application** of RFA (e.g., for chronic pain management by ablating sensory nerves) rather than the underlying physical principle. - RFA can ablate various tissue types including tumors (liver, lung, kidney), cardiac tissue (for arrhythmias), and nerves, making this option too narrow and application-specific.
Vascular Access Techniques
Practice Questions
Angiography and Angioplasty
Practice Questions
Embolization Procedures
Practice Questions
Thrombolysis and Thrombectomy
Practice Questions
Transjugular Intrahepatic Portosystemic Shunt
Practice Questions
Biliary Interventions
Practice Questions
Genitourinary Interventions
Practice Questions
Gastrointestinal Interventions
Practice Questions
Percutaneous Biopsy Techniques
Practice Questions
Drainage Procedures
Practice Questions
Tumor Ablation Techniques
Practice Questions
Venous Interventions
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free